Psychological Distress and Disability in Patients with Primary Headache: A Cross-Sectional Study Using DASS-42 and IDEAS Scale
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.114 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Bhuvneshwar Meena und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Primary headache disorders are among the most common neurological conditions and are increasingly recognized as multidimensional disorders with significant psychological and functional impact.
Objective
To assess the prevalence and severity of psychological distress and disability among patients with primary headache using the Depression Anxiety Stress Scale-42 (DASS-42) and the Indian Disability Evaluation and Assessment Scale (IDEAS).
Methods
This hospital-based cross-sectional study was conducted among 210 patients diagnosed with primary headache according to ICHD-3 criteria. Psychological distress was assessed using DASS-42, and functional disability was evaluated using IDEAS. Data were analyzed using descriptive and inferential statistics, with p
Zitieren
APA
Meena, B., Gupta, S., & Shakya, K. P. S. (2026). Psychological Distress and Disability in Patients with Primary Headache: A Cross-Sectional Study Using DASS-42 and IDEAS Scale. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.114
Vancouver
Meena B, Gupta S, Shakya KPS. Psychological Distress and Disability in Patients with Primary Headache: A Cross-Sectional Study Using DASS-42 and IDEAS Scale. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.114
BibTeX
@article{Meena2026,
author = {Meena, Bhuvneshwar and Gupta, Suresh and Shakya, Kuldeep Pratap Singh},
title = {Psychological Distress and Disability in Patients with Primary Headache: A Cross-Sectional Study Using DASS-42 and IDEAS Scale},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.114}
}
EUVIMED